Novartis Agrees to Buy Glaxo Oncology Unit for $16B

Novartis Agrees to Buy Glaxo Oncology Unit for $16B Play

April 22 (Bloomberg) –- Bloomberg’s Jonathan Ferro reports on Novartis buying Glaxo’s cancer drug assets and selling it’s animal health operation to Eli Lilly. He speaks to Anna Edwards and Mark Barton on Bloomberg Television’s “Countdown.” (Source: Bloomberg)

  • On Air Now

    In The Loop with Betty Liu Watch Now

  • Next

    Market Makers

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus